Prioritization of potential pharmacological targets for the development of anti-hepatocarcinoma drugs modulating the extrinsic apoptosis pathway: the reconstruction and analysis of associative gene networks help

П. С. Деменков, Е. А. Ощепкова, A. V. Adamovskaya, Elena Mishchenko, Т. М. Хлебодарова, Timofey Ivanisenko, Nikita V. Ivanisenko, A. S. Venzel, Inna N. Lavrik, В. А. ИванисенкоVavilov 2023 · DOI

TL;DR

Researchers have developed a computational framework to identify new drug targets for hepatocellular carcinoma (HCC) by focusing on the often-overlooked extrinsic apoptosis pathway. By integrating AI-driven literature mining with patient-specific molecular data, they identified 100 high-priority gene targets, including six top candidates (JUN, IL10, STAT3, MYC, TLR4, and KHDRBS1) that could lead to more effective liver cancer therapies.

What Problem Does This Paper Address?

Hepatocellular carcinoma (HCC) is an aggressive liver cancer with notoriously low survival rates. A hallmark of cancer is its ability to evade "programmed cell death," or apoptosis. While many existing drugs try to jumpstart the intrinsic (mitochondrial) apoptosis pathway, the extrinsic pathway—which is triggered by signals at the cell surface—remains largely untapped as a therapeutic strategy.

The challenge is that the extrinsic pathway is a complex web of interactions influenced by external factors like Hepatitis C virus (HCV) infection and epigenetic changes (specifically DNA methylation). The authors aim to map these interactions and prioritize which genes, if targeted by new drugs, would most effectively "re-enable" the cell's suicide switch in cancerous liver cells.

Methods

The researchers employed a multi-step computational approach centered on ANDSystem, an AI-powered tool designed for "associative gene network" reconstruction.

  1. Knowledge Extraction: ANDSystem automatically scanned millions of scientific publications and databases to extract facts about molecular interactions (e.g., protein-protein binding, gene regulation).
  2. Network Reconstruction: They built two primary networks: one for HCC-associated genes and another for the extrinsic apoptosis pathway.
  3. Data Integration: They refined these networks using patient-specific data, including differentially expressed genes (DEGs) and DNA methylation patterns from the Gene Expression Omnibus (GEO).
  4. Prioritization (The 13 Criteria): To rank potential targets, the team developed 13 quantitative criteria. These included:
  5. Presence in the HCC and apoptosis networks.
  6. Centrality: How "connected" a gene/protein is within regulatory pathways involving HCV proteins or aberrantly methylated genes.
  7. Methylation Status: Whether the gene is hypomethylated (overactive) or hypermethylated (silenced) in HCC.

Datasets

The study utilized several high-quality public resources:

  • GEO (Gene Expression Omnibus): Specifically, RNA-seq data from ten patients with HBV-associated HCC (Huang et al., 2011) to identify differentially expressed genes.
  • Human Protein Atlas: Used to extract a list of FDA-approved pharmacological targets for validation.
  • GeneOntology: Used to define the initial set of genes involved in the extrinsic apoptotic signaling pathway.
  • ANDSystem Knowledge Base: A proprietary database containing over 40 million facts about molecular-genetic interactions.

Key Insights and Ideas

  • The Extrinsic Pathway as a "Blue Ocean": Most research focuses on the internal mitochondrial pathway. By shifting focus to the cell-surface receptors (the extrinsic path), the authors highlight a less crowded space for drug development.
  • Validation via "Known Truths": To prove their ranking system worked, they checked if their top 100 list contained known FDA-approved drug targets. It did—19 of them, which was statistically significant ($p = 0.0002$). This gives confidence that the new targets in that list are also biologically relevant.
  • HCV and Methylation as Regulatory Hubs: The study emphasizes that we can't look at cancer genes in a vacuum. By including HCV proteins and methylation data in the network, they identified targets that are specifically relevant to the environmental and epigenetic context of liver cancer.

Key Results

The study successfully narrowed down thousands of genes to a prioritized list.

  • Top Candidates: Six genes were highlighted as particularly promising: JUN, IL10, STAT3, MYC, TLR4, and KHDRBS1.
  • JUN (Rank 1): Identified as a master regulator that can influence the expression of FASLG, a key trigger for the extrinsic apoptosis pathway.
  • TLR4 (Rank 14): While typically associated with the immune system, the network analysis showed it regulates several apoptosis markers (CFLAR, CASP8, FADD) through the NF-κB signaling pathway.
  • Network Complexity: The final reconstructed HCC network was massive, containing 627 genes, 624 proteins, 1,105 metabolites, and over 17,000 interactions.

Limitations and Future Work

The primary limitation is that this study is entirely computational. While the prioritization method is statistically validated against known drug targets, the "new" candidates (like KHDRBS1) require rigorous in vitro and in vivo experimental validation to prove they can actually be modulated to kill cancer cells.

Future work suggested by the authors involves using these prioritized targets for the computer-aided design of small molecules—essentially "digital drug discovery"—to find compounds that can specifically bind to and regulate these key nodes in the extrinsic apoptosis network.

Summary updated

Abstract

Hepatocellular carcinoma (HCC) is a common severe type of liver cancer characterized by an extremely aggressive course and low survival rates. It is known that disruptions in the regulation of apoptosis activation are some of the key features inherent in most cancer cells, which determines the pharmacological induction of apoptosis as an important strategy for cancer therapy. The computer design of chemical compounds capable of specifically regulating the external signaling pathway of apoptosis induction represents a promising approach for creating new effective ways of therapy for liver cancer and other oncological diseases. However, at present, most of the studies are devoted to pharmacological effects on the internal (mitochondrial) apoptosis pathway. In contrast, the external pathway induced via cell death receptors remains out of focus. Aberrant gene methylation, along with hepatitis C virus (HCV) infection, are important risk factors for the development of hepatocellular carcinoma. The reconstruction of gene networks describing the molecular mechanisms of interaction of aberrantly methylated genes with key participants of the extrinsic apoptosis pathway and their regulation by HCV proteins can provide important information when searching for pharmacological targets. In the present study, 13 criteria were proposed for prioritizing potential pharmacological targets for developing anti-hepatocarcinoma drugs modulating the extrinsic apoptosis pathway. The criteria are based on indicators of the structural and functional organization of reconstructed gene networks of hepatocarcinoma, the extrinsic apoptosis pathway, and regulatory pathways of virus-extrinsic apoptosis pathway interaction and aberrant gene methylation-extrinsic apoptosis pathway interaction using ANDSystem. The list of the top 100 gene targets ranked according to the prioritization rating was statistically significantly (p-value = 0.0002) enriched for known pharmacological targets approved by the FDA, indicating the correctness of the prioritization method. Among the promising potential pharmacological targets, six highly ranked genes (JUN, IL10, STAT3, MYC, TLR4, and KHDRBS1) are likely to deserve close attention.
BibTeX
@inproceedings{2023prioritization,
  author = {П. С. Деменков and Е. А. Ощепкова and A. V. Adamovskaya and Elena Mishchenko and Т. М. Хлебодарова and Timofey Ivanisenko and Nikita V. Ivanisenko and A. S. Venzel and Inna N. Lavrik and В. А. Иванисенко},
  title = {{Prioritization of potential pharmacological targets for the development of anti-hepatocarcinoma drugs modulating the extrinsic apoptosis pathway: the reconstruction and analysis of associative gene networks help}},
  booktitle = {Vavilov},
  year = {2023},
  doi = {10.18699/vjgb-23-91},
}
Figure